Back

Procedural safety and long-term outcome of zero-fluoroscopy ablation in pregnant

31 March 2025 (11:30 - 12:15)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation catheter ablation complications (2) Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Associate Professor Aliya Smagulova

NpJSC Astana Medical university, Astana (Kazakhstan)

6 More presentations in this session

Presentation thumbnail
How effective is intracardiac echocardiography in reducing cardiac tamponades
Doctor R. Landen (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Complications and adverse events after atrial fibrillation catheter ablation procedures: a Nationwide Cohort Study
Mr A. Lappalainen (Kuopio, FI)
Abstract Slides Video
Presentation thumbnail
Epicardial adipose tissue interference in atrial fibrillation (AF) ablation depending on energy sources: high power short duration vs. Pulsed Field energy
Doctor F. Englert (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Periprocedural assessment of intravascular hemolysis and renal function during atrial fibrillation ablation using pulse field and cryoablation - preliminary results
Doctor P. Denysiuk (Lublin, PL)
Abstract Slides Video
Presentation thumbnail
Comparative analysis of femoral vein access techniques in atrial fibrillation ablation: reducing groin complications with ultrasound-guided micropuncture
Doctor H. Uuetoa (Gothenburg, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation catheter ablation complications (2)

The Event

Event poster

EHRA 2025

31 March 2025 11:30 CET
You may be interested in
thumbnail
Congress Presentation
Non-fluoroscopic approach: a novel workflow for catheter ablation of arrhythmias in pregnant
thumbnail
Congress Presentation
Clinical characteristic and zero-fluoroscopy ablation outcomes of tachyarrhythmias in pregnant: a single center study
thumbnail
Congress Presentation
Safety, obstetric and neonatal data trend of novel arrhythmia management in pregnant: zero-fluoroscopy catheter ablation vs. antiarrhythmic drugs

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources